Select Medical Holdings 미래 성장

Future 기준 확인 3/6

Select Medical Holdings (는) 각각 연간 33.5% 및 5.3% 수익과 수익이 증가할 것으로 예상됩니다. EPS는 연간 33.8% 만큼 성장할 것으로 예상됩니다. 자기자본이익률은 3년 후 8.5% 로 예상됩니다.

주요 정보

33.5%

수익 성장률

33.76%

EPS 성장률

Healthcare 수익 성장	13.6%
매출 성장률	5.3%
향후 자기자본 수익률	8.48%
애널리스트 커버리지	Low
마지막 업데이트	07 May 2025

최근 미래 성장 업데이트

Recent updates

Investors Still Waiting For A Pull Back In Select Medical Holdings Corporation (NYSE:SEM)

May 30

Is Now The Time To Look At Buying Select Medical Holdings Corporation (NYSE:SEM)?

May 10

Select Medical Holdings' (NYSE:SEM) Conservative Accounting Might Explain Soft Earnings

Feb 28

Should You Think About Buying Select Medical Holdings Corporation (NYSE:SEM) Now?

Nov 22

What Does Select Medical Holdings Corporation's (NYSE:SEM) Share Price Indicate?

Jul 01

Does Select Medical Holdings (NYSE:SEM) Have A Healthy Balance Sheet?

Jun 13

There's Reason For Concern Over Select Medical Holdings Corporation's (NYSE:SEM) Price

May 26

Results: Select Medical Holdings Corporation Exceeded Expectations And The Consensus Has Updated Its Estimates

May 05

Here's Why Shareholders Should Examine Select Medical Holdings Corporation's (NYSE:SEM) CEO Compensation Package More Closely

Apr 19

Returns At Select Medical Holdings (NYSE:SEM) Appear To Be Weighed Down

Apr 11

Select Medical: Solid Growth Prospects And A Compelling Valuation

Mar 05

Cautious Investors Not Rewarding Select Medical Holdings Corporation's (NYSE:SEM) Performance Completely

Feb 18

We Think Select Medical Holdings (NYSE:SEM) Is Taking Some Risk With Its Debt

Jan 15

Returns On Capital At Select Medical Holdings (NYSE:SEM) Have Hit The Brakes

Dec 31

Select Medical Holdings (NYSE:SEM) Is Due To Pay A Dividend Of $0.125

Nov 06

Select Medical: Market Expectations Appear Well Justified With Technical And Economic Factors

Oct 25

What Does Select Medical Holdings Corporation's (NYSE:SEM) Share Price Indicate?

Oct 04

Is Select Medical Holdings (NYSE:SEM) Using Too Much Debt?

Sep 16

Select Medical: Capital Charge Now $6.1Bn At C.6% Trailing Returns, Reiterate Hold

Aug 11

Select Medical Holdings (NYSE:SEM) Will Pay A Dividend Of $0.125

Aug 07

Select Medical Holdings (NYSE:SEM) Has More To Do To Multiply In Value Going Forward

Jul 14

수익 및 매출 성장 예측

NYSE:SEM - 애널리스트의 미래 추정치 및 과거 재무 데이터 (USD Millions )
날짜	수익	수익	잉여 현금 흐름	작전 현금	평균 애널리스트 수
12/31/2027	6,041	205	286	494	2
12/31/2026	5,717	237	272	470	5
12/31/2025	5,414	197	250	437	5
3/31/2025	5,219	61	359	581	N/A
12/31/2024	5,187	45	296	518	N/A
9/30/2024	4,663	30	353	572	N/A
6/30/2024	4,567	23	288	507	N/A
3/31/2024	4,482	24	241	464	N/A
12/31/2023	4,826	52	353	582	N/A
9/30/2023	6,587	217	191	415	N/A
6/30/2023	6,489	196	177	393	N/A
3/31/2023	6,399	174	128	330	N/A
12/31/2022	4,609	-20	94	285	N/A
9/30/2022	6,312	175	21	212	N/A
6/30/2022	6,278	223	19	216	N/A
3/31/2022	6,258	329	-20	168	N/A
12/31/2021	6,205	389	221	401	N/A
9/30/2021	6,105	415	503	669	N/A
6/30/2021	5,995	415	553	705	N/A
3/31/2021	5,664	306	1,077	1,224	N/A
12/31/2020	5,532	250	882	1,028	N/A
9/30/2020	5,446	206	860	999	N/A
6/30/2020	5,415	162	859	998	N/A
3/31/2020	5,544	155	300	448	N/A
12/31/2019	5,454	143	288	445	N/A
9/30/2019	5,344	136	210	380	N/A
6/30/2019	5,218	138	235	410	N/A
3/31/2019	5,153	140	308	485	N/A
12/31/2018	5,081	133	N/A	494	N/A
9/30/2018	4,911	207	N/A	489	N/A
6/30/2018	4,720	193	N/A	415	N/A
3/31/2018	4,527	189	N/A	345	N/A
12/31/2017	4,365	171	N/A	238	N/A
9/30/2017	4,300	93	N/A	196	N/A
6/30/2017	4,259	82	N/A	209	N/A
3/31/2017	4,237	74	N/A	180	N/A
12/31/2016	4,217	112	N/A	347	N/A
9/30/2016	4,211	121	N/A	286	N/A
6/30/2016	4,178	143	N/A	312	N/A
3/31/2016	3,973	146	N/A	282	N/A
12/31/2015	3,683	127	N/A	208	N/A
9/30/2015	3,420	123	N/A	222	N/A
6/30/2015	3,165	121	N/A	204	N/A
3/31/2015	3,052	119	N/A	224	N/A
12/31/2014	3,020	117	N/A	171	N/A
9/30/2014	2,997	121	N/A	230	N/A
6/30/2014	2,963	118	N/A	213	N/A

애널리스트 미래 성장 예측

수입 대 저축률: SEM 의 연간 예상 수익 증가율( 33.5% )이 saving rate( 2.9% 보다 높습니다. ).

수익 vs 시장: SEM 의 연간 수익( 33.5% ) US 시장( 14.4% 보다 빠르게 성장할 것으로 예상됩니다. 14.4% 연간).

고성장 수익: SEM 의 수입은 향후 3년 동안 상당히 증가할 것으로 예상됩니다.

수익 대 시장: SEM 의 수익(연간 5.3% ) US 시장( 8.6% 보다 느리게 성장할 것으로 예상됩니다. 8.6% 연간).

고성장 수익: SEM 의 수익(연간 5.3% )은 연간 20% 보다 느리게 증가할 것으로 예상됩니다.

주당 순이익 성장 예측

미래 자기자본 수익률

미래 ROE: SEM 의 자본 수익률은 3년 내에 최저 수준이 될 것으로 예상됩니다( 8.5 %).

성장 기업 발견

기업 분석 및 재무 데이터 현황

데이터	마지막 업데이트(UTC 시간)
기업 분석	2025/05/29 16:57
장 마감 주가	2025/05/29 00:00
수익	2025/03/31
연간 수익	2024/12/31

데이터 소스

기업 분석에 사용된 데이터는 S&P Global Market Intelligence LLC의 데이터입니다. 이 보고서를 생성하기 위해 분석 모델에 사용된 데이터는 다음과 같습니다. 데이터는 정규화되어 있으므로 소스가 제공되기까지 지연이 발생할 수 있습니다.

패키지	데이터	기간	미국 소스 예시 ^*
회사 재무	10년	손익 계산서 현금 흐름표 대차 대조표	SEC 양식 10-K SEC 양식 10-Q
애널리스트 컨센서스 추정치	+3년	재무 예측 애널리스트 목표가	애널리스트 연구 보고서 Blue Matrix
시장 가격	30년	주식 가격 배당금, 분할 및 액션	ICE 시장 데이터 SEC 양식 S-1
소유권	10년	최대 주주 내부자 거래	SEC 양식 4 SEC 양식 13D
관리	10년	리더십 팀 이사회	SEC 양식 10-K SEC 양식 DEF 14A
주요 개발 사항	10년	회사 공지 사항	SEC 양식 8-K

* 미국 증권의 경우, 미국 외 지역의 규제 양식 및 출처는 미국 증권의 예를 사용했습니다.

명시되지 않는 한 모든 재무 데이터는 1년을 기준으로 하지만 분기별로 업데이트됩니다. 이를 후행 12개월(TTM) 또는 최근 12개월(LTM) 데이터라고 합니다. 자세히 알아보기.

분석 모델 및 눈송이

이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 Github 페이지에서 확인할 수 있으며, 보고서 사용 방법에 대한 가이드와 튜토리얼도 유튜브에서 확인할 수 있습니다.

Simply 월스트리트 분석 모델을 설계하고 구축한 세계적인 수준의 팀에 대해 알아보세요.

산업 및 부문 메트릭

업계 및 섹션 지표는 Simply Wall St에서 6시간마다 계산되며, 자세한 내용은 Github에서 확인할 수 있습니다.

애널리스트 출처

Select Medical Holdings Corporation 18 애널리스트 중 5 애널리스트가 보고서의 입력 자료로 사용된 매출 또는 수익 추정치를 제출했습니다. 애널리스트의 제출 자료는 하루 종일 업데이트됩니다.

분석가	교육기관
Brian Williams	Avondale Partners
Benjamin Mayo	Baird
William Sutherland	Benchmark Company

Select Medical Holdings 미래 성장

Future 기준 확인 3/6

주요 정보

최근 미래 성장 업데이트

Price target decreased by 8.6% to US$21.17

Select Medical Holdings Corporation Provides Earnings Guidance for the Year 2025

Select Medical Holdings Corporation Provides Earnings Guidance for the Year Ending December 31, 2025

Price target decreased by 23% to US$34.25

Select Medical Holdings Corporation Updates Earnings Guidance for the Year Ending December 31, 2024

Price target increased by 8.9% to US$39.00

Recent updates

Investors Still Waiting For A Pull Back In Select Medical Holdings Corporation (NYSE:SEM)

Is Now The Time To Look At Buying Select Medical Holdings Corporation (NYSE:SEM)?

Independent Director recently bought US$315k worth of stock

Price target decreased by 8.6% to US$21.17

Dividend of US$0.063 announced

First quarter 2025 earnings: EPS and revenues miss analyst expectations

Select Medical Holdings Corporation Provides Earnings Guidance for the Year 2025

Director & CEO notifies of intention to sell stock

Investor sentiment improves as stock rises 17%

Select Medical Holdings Corporation to Report Q1, 2025 Results on May 01, 2025

Select Medical Holdings' (NYSE:SEM) Conservative Accounting Might Explain Soft Earnings

Dividend of US$0.063 announced

New major risk - Revenue and earnings growth

Select Medical Holdings Corporation, Annual General Meeting, Apr 24, 2025

Select Medical Holdings Corporation Declares Cash Dividend, Payable on or About March 13, 2025

Full year 2024 earnings: EPS and revenues miss analyst expectations

Select Medical Holdings Corporation Provides Earnings Guidance for the Year Ending December 31, 2025

Select Medical Holdings Corporation to Report Q4, 2024 Results on Feb 20, 2025

Price target decreased by 23% to US$34.25

Insufficient new directors

Select Medical Holdings Corporation completed the Spin-Off of Concentra Group Holdings, LLC.

Should You Think About Buying Select Medical Holdings Corporation (NYSE:SEM) Now?

Insufficient new directors

Investor sentiment improves as stock rises 17%

Select Medical Holdings' (NYSE:SEM) Dividend Will Be $0.125

Third quarter dividend of US$0.13 announced

Third quarter 2024 earnings: EPS and revenues exceed analyst expectations

Select Medical Holdings Corporation Updates Earnings Guidance for the Year Ending December 31, 2024

Returns Are Gaining Momentum At Select Medical Holdings (NYSE:SEM)

Select Medical Holdings: No Reason To Downgrade This One Just Yet

Does Select Medical Holdings (NYSE:SEM) Have A Healthy Balance Sheet?

Select Medical Holdings Corporation to Report Q3, 2024 Results on Oct 31, 2024

Critical Moves To Bolster Efficiency And Shareholder Wealth

Select Medical Holdings' (NYSE:SEM) Dividend Will Be $0.125

Second quarter dividend of US$0.13 announced

Second quarter 2024 earnings: EPS misses analyst expectations

Select Medical Holdings Corporation Declares a Cash Dividend, Payable on or About August 30, 2024

Select Medical Holdings' (NYSE:SEM) Returns On Capital Are Heading Higher

What Does Select Medical Holdings Corporation's (NYSE:SEM) Share Price Indicate?

Select Medical Holdings Corporation to Report Q2, 2024 Results on Aug 01, 2024

Does Select Medical Holdings (NYSE:SEM) Have A Healthy Balance Sheet?

There's Reason For Concern Over Select Medical Holdings Corporation's (NYSE:SEM) Price

Price target increased by 8.9% to US$39.00

Investor sentiment improves as stock rises 17%

First quarter dividend of US$0.13 announced

Results: Select Medical Holdings Corporation Exceeded Expectations And The Consensus Has Updated Its Estimates

New minor risk - Shareholder dilution

First quarter 2024 earnings: EPS and revenues exceed analyst expectations

Select Medical Reaffirms Earnings Guidance for the Year 2024

Insufficient new directors

Here's Why Shareholders Should Examine Select Medical Holdings Corporation's (NYSE:SEM) CEO Compensation Package More Closely

Returns At Select Medical Holdings (NYSE:SEM) Appear To Be Weighed Down

Co-Founder & Executive Chairman notifies of intention to sell stock

Select Medical Holdings Corporation to Report Q1, 2024 Results on May 02, 2024

Select Medical Holdings Corporation, Annual General Meeting, Apr 25, 2024

Co-Founder & Executive Chairman notifies of intention to sell stock

Price target increased by 7.5% to US$35.80

Select Medical: Solid Growth Prospects And A Compelling Valuation

Fourth quarter dividend of US$0.13 announced

Full year 2023 earnings: EPS misses analyst expectations

Select Medical Holdings Corporation Declares Cash Dividend, Payable on or About March 13, 2024

Cautious Investors Not Rewarding Select Medical Holdings Corporation's (NYSE:SEM) Performance Completely

Co-Founder & Executive Chairman notifies of intention to sell stock

Select Medical Holdings Corporation to Report Q4, 2023 Results on Feb 22, 2024

We Think Select Medical Holdings (NYSE:SEM) Is Taking Some Risk With Its Debt

Co-Founder & Executive Chairman notifies of intention to sell stock

Returns On Capital At Select Medical Holdings (NYSE:SEM) Have Hit The Brakes

Co-Founder & Executive Chairman notifies of intention to sell stock

Upcoming dividend of US$0.13 per share at 2.3% yield